Different outcomes for transplant-eligible newly diagnosed multiple myeloma patients in Latin America according to the public versus private management: a GELAMM study
2020; Taylor & Francis; Volume: 61; Issue: 13 Linguagem: Inglês
10.1080/10428194.2020.1804558
ISSN1042-8194
AutoresCamila Peña, Eloísa Riva, Natalia Schütz, Luz Tarín‐Arzaga, Humberto Martínez‐Cordero, Virginia Bove, Rocío Osorio, Mauricio Chandía, Cecilia Beltrán, Javier Schulz, Daniela Cardemil, Carolina Contreras, Carmen Vergara, Javiera Donoso, Marcela Espinoza, Gabriel La Rocca, Hernán López‐Vidal, Pilar Leόn, Christine Rojas Hopkins, Pablo Soto, Sandra Aranda, Vivianne Torres, Macarena Roa, Paola Ochoa, Patricio Duarte, Guillermina Remaggi, Sebastián Yantorno, Ariel Corzo, Soledad Zabaljauregui, Claudia Shanley, Sergio Lopresti, Sérgio Orlando, Verónica Verri, Luis Quiroga, Carlos García, Vanesa Alonso, Jhoanna Ramírez, Alicia Molina, María Pacheco, Alex Mite, Inés Reyes, Brenner Sabando, Francisca Ramírez, Claudia Sossa, Virginia Abello, Henry Idrobo, Kenny Gálvez, Domingo Saavedra, Guillermo Quintero, Raimundo Gazitúa, Lina María Gaviria, Rigoberto Gómez, Mónica Osuna, Alicia Henao-Uribe, Omar Cantú-Martínez, David Gómez‐Almaguer, Yarely Itzayana García-Navarrete, Antonio Cruz-Mora, Yahveth Cantero‐Fortiz, Guillermo J. Ruíz‐Argüelles, Dorotea Fantl,
Tópico(s)Myeloproliferative Neoplasms: Diagnosis and Treatment
ResumoThe aim of this study was to describe clinical and survival characteristics of transplant-eligible multiple myeloma (MM) patients in Latin America (LA), with a special focus on differences between public and private healthcare facilities. We included 1293 patients diagnosed between 2010 and 2018. A great disparity in outcomes and survival between both groups was observed. Late diagnosis and low access to adequate frontline therapy and ASCT in public institutions probably explain these differences. Patients treated with novel drug induction protocols, followed by autologous stem cell transplantation (ASCT) and maintenance, have similar overall survival compared to that published internationally.
Referência(s)